4-[1-[2-(methylamino)-2-oxoethyl]pyrazol-4-yl]-N-[(3S)-1-methyl-6-oxopiperidin-3-yl]benzamide
C19H23N5O3 — CID 125436273
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[1-[2-(methylamino)-2-oxoethyl]pyrazol-4-yl]-N-[(3S)-1-methyl-6-oxopiperidin-3-yl]benzamide
4-[1-[2-(methylamino)-2-oxoethyl]pyrazol-4-yl]-N-[(3S)-1-methyl-6-oxopiperidin-3-yl]benzamide (PubChem CID 125436273) has the molecular formula C19H23N5O3 and a molecular weight of 369.43 g/mol. Its IUPAC name is 4-[1-[2-(methylamino)-2-oxoethyl]pyrazol-4-yl]-N-[(3S)-1-methyl-6-oxopiperidin-3-yl]benzamide.
Molecular Properties
| Compound Name | 4-[1-[2-(methylamino)-2-oxoethyl]pyrazol-4-yl]-N-[(3S)-1-methyl-6-oxopiperidin-3-yl]benzamide |
|---|---|
| PubChem CID | 125436273 |
| Molecular Formula | C19H23N5O3 |
| Molecular Weight | 369.43 g/mol |
| Exact Mass | 369.18 |
| IUPAC Name | 4-[1-[2-(methylamino)-2-oxoethyl]pyrazol-4-yl]-N-[(3S)-1-methyl-6-oxopiperidin-3-yl]benzamide |
| SMILES | CNC(=O)Cn1cc(-c2ccc(C(=O)N[C@H]3CCC(=O)N(C)C3)cc2)cn1 |
| InChI | InChI=1S/C19H23N5O3/c1-20-17(25)12-24-10-15(9-21-24)13-3-5-14(6-4-13)19(27)22-16-7-8-18(26)23(2)11-16/h3-6,9-10,16H,7-8,11-12H2,1-2H3,(H,20,25)(H,22,27)/t16-/m0/s1 |
| InChIKey | LPYWGYVXOGURII-INIZCTEOSA-N |
| XLogP | 0.65 |
| TPSA | 96.33 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 369.43 |
| LogP ≤ 5 | 0.65 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 125436273 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.